Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings

NCT00091936 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

592

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Tuberculosis

Interventions

DRUG: Didanosine
DRUG: Efavirenz
DRUG: Lamivudine
DRUG: Standard TB treatment

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)